HEALTHCARE REALTY TRUST INC (HR)
US42226K1051 - REIT
Overall HR gets a fundamental rating of 2 out of 10. We evaluated HR against 129 industry peers in the Diversified REITs industry. HR may be in some trouble as it scores bad on both profitability and health. HR is valued expensive and it does not seem to be growing.
1. Profitability
1.1 Basic Checks
In the past year HR has reported negative net income.
HR had a positive operating cash flow in the past year.
HR had positive earnings in 4 of the past 5 years.
HR had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
HR has a worse Return On Assets (-2.23%) than 77.17% of its industry peers.
HR's Return On Equity of -4.13% is on the low side compared to the rest of the industry. HR is outperformed by 69.29% of its industry peers.
HR has a Return On Invested Capital of 0.35%. This is amonst the worse of the industry: HR underperforms 90.55% of its industry peers.
HR had an Average Return On Invested Capital over the past 3 years of 1.01%. This is below the industry average of 3.05%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -2.23% | ||
| ROE | -4.13% | ||
| ROIC | 0.35% |
ROA(3y)-0.18%
ROA(5y)0.14%
ROE(3y)-0.2%
ROE(5y)0.39%
ROIC(3y)1.01%
ROIC(5y)1.4%
1.3 Margins
Looking at the Operating Margin, with a value of 4.04%, HR is doing worse than 90.55% of the companies in the same industry.
HR's Operating Margin has declined in the last couple of years.
With a Gross Margin value of 62.76%, HR is not doing good in the industry: 66.14% of the companies in the same industry are doing better.
In the last couple of years the Gross Margin of HR has declined.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 4.04% | ||
| PM (TTM) | N/A | ||
| GM | 62.76% |
OM growth 3Y-43.5%
OM growth 5Y-29.46%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.25%
GM growth 5Y-1.68%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), HR is destroying value.
Compared to 1 year ago, HR has about the same amount of shares outstanding.
Compared to 5 years ago, HR has more shares outstanding
Compared to 1 year ago, HR has a worse debt to assets ratio.
2.2 Solvency
Based on the Altman-Z score of 0.43, we must say that HR is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 0.43, HR is doing worse than 61.42% of the companies in the same industry.
The Debt to FCF ratio of HR is 28.39, which is on the high side as it means it would take HR, 28.39 years of fcf income to pay off all of its debts.
With a decent Debt to FCF ratio value of 28.39, HR is doing good in the industry, outperforming 64.57% of the companies in the same industry.
HR has a Debt/Equity ratio of 0.74. This is a neutral value indicating HR is somewhat dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.74, HR is in the better half of the industry, outperforming 73.23% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.74 | ||
| Debt/FCF | 28.39 | ||
| Altman-Z | 0.43 |
ROIC/WACC0.06
WACC6.19%
2.3 Liquidity
A Current Ratio of 0.47 indicates that HR may have some problems paying its short term obligations.
The Current ratio of HR (0.47) is worse than 88.19% of its industry peers.
A Quick Ratio of 0.47 indicates that HR may have some problems paying its short term obligations.
HR has a Quick ratio of 0.47. This is amonst the worse of the industry: HR underperforms 85.04% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.47 | ||
| Quick Ratio | 0.47 |
3. Growth
3.1 Past
The earnings per share for HR have decreased strongly by -82.61% in the last year.
Looking at the last year, HR shows a very strong growth in Revenue. The Revenue has grown by 44.09%.
Measured over the past years, HR shows a quite strong growth in Revenue. The Revenue has been growing by 14.05% on average per year.
EPS 1Y (TTM)-82.61%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-77.27%
Revenue 1Y (TTM)44.09%
Revenue growth 3Y22.06%
Revenue growth 5Y14.05%
Sales Q2Q%-6.45%
3.2 Future
The Earnings Per Share is expected to grow by 10.28% on average over the next years. This is quite good.
HR is expected to show a decrease in Revenue. In the coming years, the Revenue will decrease by -1.00% yearly.
EPS Next Y-72.13%
EPS Next 2Y17.54%
EPS Next 3Y10.28%
EPS Next 5YN/A
Revenue Next Year-5.68%
Revenue Next 2Y-2.62%
Revenue Next 3Y-1%
Revenue Next 5YN/A
3.3 Evolution
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings Ratio is negative for HR. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for HR. No positive earnings are expected for the next year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
HR's Enterprise Value to EBITDA ratio is in line with the industry average.
Based on the Price/Free Cash Flow ratio, HR is valued a bit cheaper than 65.35% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 34.83 | ||
| EV/EBITDA | 14.35 |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y17.54%
EPS Next 3Y10.28%
5. Dividend
5.1 Amount
HR has a Yearly Dividend Yield of 7.03%, which is a nice return.
Compared to an average industry Dividend Yield of 5.79, HR pays a better dividend. On top of this HR pays more dividend than 81.89% of the companies listed in the same industry.
Compared to an average S&P500 Dividend Yield of 2.22, HR pays a better dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 7.03% |
5.2 History
The dividend of HR decreases each year by -14.26%.
HR has been paying a dividend for at least 10 years, so it has a reliable track record.
Dividend Growth(5Y)-14.26%
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
The earnings of HR are negative and hence is the payout ratio. HR will probably not be able to sustain this dividend level.
DP-167.7%
EPS Next 2Y17.54%
EPS Next 3Y10.28%
HEALTHCARE REALTY TRUST INC
NYSE:HR (10/8/2024, 8:04:00 PM)
After market: 17.13 0 (0%)17.13
-0.26 (-1.5%)
Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryDiversified REITs
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap6.22B
Analysts
Price Target
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 7.03% |
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | |||
| P/FCF | |||
| P/OCF | |||
| P/B | |||
| P/tB | |||
| EV/EBITDA |
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -2.23% | ||
| ROE | -4.13% | ||
| ROCE | |||
| ROIC | |||
| ROICexc | |||
| ROICexgc | |||
| OM | 4.04% | ||
| PM (TTM) | N/A | ||
| GM | 62.76% | ||
| FCFM |
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.11
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.74 | ||
| Debt/FCF | |||
| Debt/EBITDA | |||
| Cap/Depr | |||
| Cap/Sales | |||
| Interest Coverage | |||
| Cash Conversion | |||
| Profit Quality | |||
| Current Ratio | 0.47 | ||
| Quick Ratio | 0.47 | ||
| Altman-Z |
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)-82.61%
EPS 3YN/A
EPS 5Y
EPS Q2Q%
EPS Next Y-72.13%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)44.09%
Revenue growth 3Y22.06%
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y